I agree. The amount of blood to test for a simple sugar can be done with a pin prick, but to test for the staggering number of cancers would be more in the "vial" range, I would think. As we saw from another poster, they have been having varying success with blood testing for different cancer types. However, breast cancer was one of the least successfully detected and at a fairly late stage. Once again, like mammograms for dense breast tissue and blood tests specifically for breast cancer, neither met the "early" detection goal. And a five-year study is not an eminent danger for the least invasive device with the most accuracy, which is the iT-Bra.
The iT-Bra is not meant to replace any other procedure or doctor's supervision, but to aid and supplement it where earlier detection is key. And, although the Asian market sales won't be a huge windfall to the bottom line of Cyrcadia Health U.S., it will be a great aid to manufacturing and marketing in the United States and other countries (hopefully) THIS year. We always have to be cautiously optimistic talking about years when previous estimates haven't materialized, but there are more concrete steps visible to have the hopefully optimistic sentiment.
News 
Market Data 
Discover 
